Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

10378	Companies
216369	Keywords
146018	Articles
114531	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 10/19/2024 at 12:28, 1 year 6 months ago

Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM)
Pentixapharm presents CXCR4 targeting compounds in 17 abstracts at EANM Congress, showcasing theranostic developments and research initiatives in various medical areas

Radiopharmaceuticals Pentixapharm Theranostic Development CXCR4 EANM Congress
BRIEF

published on 10/18/2024 at 15:54, 1 year 6 months ago

EMA Awards PRIME Status to Pentixapharm's Ga68-PentixaFor

Pentixapharm Ga68-PentixaFor Primary Aldosteronism PRIME Status Radiodiagnostic
BRIEF

published on 10/18/2024 at 15:54, 1 year 6 months ago

L'EMA attribue le statut PRIME au Ga68-PentixaFor de Pentixapharm

Pentixapharm Ga68-PentixaPour Radiodiagnostic Statut PRIME Hyperaldostéronisme Primaire
PRESS RELEASE

published on 10/18/2024 at 15:49, 1 year 6 months ago

EQS-Adhoc: EMA Grants PRIME Status to Pentixapharm’s Lead Candidate PentixaFor
EMA grants PRIME status to Pentixapharm’s lead candidate Ga68-PentixaFor, offering early and proactive support for radiodiagnostic development in primary aldosteronism. PentixaFor aims to transform diagnostic subtyping with non-invasive PET imaging targeting CXCR4

Pentixapharm Ga68-PentixaFor Primary Aldosteronism PRIME Status Radiodiagnostic
BRIEF

published on 10/03/2024 at 12:03, 1 year 7 months ago

Pentixapharm Holding AG Lists on Frankfurt Stock Exchange

Frankfurt Stock Exchange IPO Biopharmaceuticals Radiopharmaceuticals Pentixapharm
BRIEF

published on 10/03/2024 at 12:03, 1 year 7 months ago

Pentixapharm Holding AG est cotée à la Bourse de Francfort

Bourse De Francfort Introduction En Bourse Produits Biopharmaceutiques Produits Radiopharmaceutiques Pentixapharm
PRESS RELEASE

published on 10/03/2024 at 11:58, 1 year 7 months ago

Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange
Pentixapharm Holding AG debuts in Prime Standard of Frankfurt Stock Exchange with IPO. Focus on radiopharmaceuticals for blood cancers

Frankfurt Stock Exchange IPO Biopharmaceutical Radiopharmaceuticals Pentixapharm
BRIEF

published on 10/01/2024 at 18:53, 1 year 7 months ago

Pentixapharm Holding AG Sets IPO Placement Price at EUR 5.10 per Share

Securities Frankfurt Stock Exchange IPO Market Capitalization Pentixapharm
BRIEF

published on 10/01/2024 at 18:53, 1 year 7 months ago

Pentixapharm Holding AG fixe le prix de son introduction en bourse à 5,10 euros par action

Titres Bourse De Francfort Capitalisation Boursière Introduction En Bourse Pentixapharm
PRESS RELEASE

published on 10/01/2024 at 18:48, 1 year 7 months ago

EQS-Adhoc: Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed
Pentixapharm Holding AG sets IPO placement price at EUR 5.10 per share, placing all 3.9 million offer shares. Gross proceeds reach EUR 19.9 million. Post-money market capitalization at EUR 126.5 million

IPO Market Capitalization Pentixapharm Holding AG Placement Price Offer Shares

Accesswire

Published on 05/11/2026 at 09:05, 3 hours 6 minutes ago

Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 4 hours 6 minutes ago

Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:55, 2 days 10 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 2 days 10 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 2 days 10 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.

View all ACCESSWIRE

EQS Group

Published on 05/11/2026 at 11:36, 35 minutes ago

LION Smart and LEAPENERGY secure the performance of their storage containers through multiple guarantees
Published on 05/11/2026 at 11:17, 54 minutes ago

Aroundtown SA: Release of a capital market information
Published on 05/11/2026 at 11:15, 56 minutes ago

POS-Transaction in Own Shares
Published on 05/11/2026 at 11:10, 1 hour 1 minute ago

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Published on 05/11/2026 at 11:09, 1 hour 2 minutes ago

Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market

Les Echos

Published on 05/11/2026 at 10:48, 1 hour 23 minutes ago

GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 1 hour 23 minutes ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 2 hours 55 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 16 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 16 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote

View all LES ECHOS COMFI WIRE